NEW YORK, March 5, 2014 /PRNewswire/ --
Today, Analysts Review released its analysts' notes regarding Cardinal Health, Inc. (NYSE: CAH), AmerisourceBergen Corporation (NYSE: ABC), Henry Schein, Inc. (NASDAQ: HSIC), Patterson Companies Inc. (NASDAQ: PDCO), and Medical Properties Trust Inc. (NYSE: MPW). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
--
Cardinal Health, Inc. Analyst Notes
On March 3, 3014, Cardinal Health, Inc. (Cardinal Health) announced that it has enhanced its integrated services for biopharmaceutical manufacturers by accomplishing the acquisition of Dallas-based Sonexus Health. The Company stated that this acquisition will help its clients address challenges being faced by the manufacturers of high-touch, high-cost specialty drugs; by the physicians who prescribe these medications; and by the patients who purchase them. Commenting on the development, Scott Howell, M.D., Senior Vice President of Clinical Affairs for Cardinal Health Specialty Solutions, said, "The addition of Sonexus Health to our portfolio brings us even closer to the patient, by enabling us to provide a next generation solution to help clients ensure that patients who need specialty medications can get faster access to them, and the right services to improve clinical outcomes." Cardinal Health informed that the base of Sonexus Health's operations will remain in Dallas, and customers will continue to be served in the same service model currently offered. The full analyst notes on Cardinal Health, Inc. are available to download free of charge at:
http://www.AnalystsReview.com/03052014/CAH/report.pdf
--
AmerisourceBergen Corporation Analyst Notes
On March 3, 2014, AmerisourceBergen Corporation's (AmerisourceBergen) stock declined 0.52%, ending the day at $67.50. Over the previous three trading sessions, shares of AmerisourceBergen have declined 1.11%, compared to the Dow Jones Industrial Average which declined 0.19% during the same period. The full analyst notes on AmerisourceBergen Corporation are available to download free of charge at:
http://www.AnalystsReview.com/03052014/ABC/report.pdf
--
Henry Schein, Inc. Analyst Notes
On February 28, 2014, Henry Schein, Inc. (Henry Schein) reported that it has been ranked first in the Wholesale: Health Care industry on the FORTUNE magazine's "World's Most Admired Companies" list for 2014. The Company also landed first place for each of the nine sub-categories of the ranking including: Innovation, People Management, Use of Corporate Assets, Social Responsibility, Quality of Management, Financial Soundness, Long-Term Investment, Quality of Products/Services, and Global Competitiveness. Henry Schein informed that 2014 marks the 13th consecutive year that Henry Schein has been selected as a FORTUNE Most Admired company. Stanley M. Bergman, Chairman of the Board and CEO of Henry Schein, commented, "We are honored to have been ranked first in our industry in Fortune's 2014 list of the World's Most Admired Companies." The full analyst notes on Henry Schein, Inc. are available to download free of charge at:
http://www.AnalystsReview.com/03052014/HSIC/report.pdf
--
Patterson Companies Inc. Analyst Notes
On February 20, 2014, Patterson Companies Inc. (Patterson) announced that it was recently recognized at Oral Health America's annual gala for its significant contribution in both monetary and in-kind donations in 2013. Commenting on the development, Scott P. Anderson, Chairman and CEO of Patterson, said, "Patterson has always maintained a strong focus on giving back to the community and improving the quality of life for others. We are proud to provide meaningful support to Oral Health America, which allows them to further their mission of changing lives by providing communities across the country access to quality dental care. I would like to thank our team at Patterson for giving their time and talent to support Oral Health America through a number of activities." The full analyst notes on Patterson Companies Inc. are available to download free of charge at:
http://www.AnalystsReview.com/03052014/PDCO/report.pdf
--
Medical Properties Trust Inc. Analyst Notes
On February 21, 2014, Medical Properties Trust Inc. (Medical Properties Trust) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.21 per share of common stock, payable on April 11, 2014, to stockholders of record on March 14, 2014. The Company also declared that its annual meeting will take place at the Summit Club in Birmingham, Alabama at 10:30 a.m. CT on May 15, 2014, for shareholders of record as of March 21, 2014. The full analyst notes on Medical Properties Trust Inc. are available to download free of charge at:
http://www.AnalystsReview.com/03052014/MPW/report.pdf
----
About Analysts Review
We provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.
--
=============
EDITOR NOTES:
- This is not company news. We are an independent source and our views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
- This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
- If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] AnalystsReview.com.
- For any urgent concerns or inquiries, please contact us at compliance [at] AnalystsReview.com.
- Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] AnalystsReview.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Analysts Review in this article or report according to the Procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts Review
